Related Experiment Video
Updated: Jun 22, 2026

Assessing the Autonomic and Behavioral Effects of Passive Motion in Rats using Elevator Vertical Motion and Ferris-Wheel Rotation
Published on: February 7, 2020
Motion sickness may be caused by a neurohumoral action of acetylcholine
1Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, 1020 Locust Street, Philadelphia, PA 19038, USA. leonard.eisenman@jefferson.edu
Abstract:
The mechanism by which motion stimulation results in the autonomic responses, known as motion sickness, has remained somewhat of an enigma. Neural connections between the vestibular nuclei and the autonomic and emetic centers in the brainstem have been described, but these appear to be relatively sparse. Thus, new or additional mechanisms seem warranted to account for this curious relationship. A new hypothesis is herein presented which posits that acetylcholine (ACh) acts as a neurohumeral agent to bring about the symptoms associated with motion sickness. Motion stimulation will activate primary vestibular afferents leading to activation of secondary vestibulocerebellar fibers, some of which are cholinergic, projecting to the vestibulocerebellar region of the posterior cerebellum. The acetylcholine, once released from these synaptic terminals diffuses into the CSF in the 4th ventricle. From there it gains access to the autonomic and emetic centers within the dorsal brainstem and can activate the cholinergic receptors in these nuclei to produce the symptoms characteristic of motion sickness. In similar fashion ACh would have access to the vestibular nuclei where it will facilitate transmission in these nuclei further reinforcing the vestibulocerebellar activity. This would serve as a positive feedback loop which will result in additional release of ACh from the cerebellum and further activation of the brainstem nuclei that result in the symptoms of motion sickness.
Related Concept Videos
Equilibrium and Balance
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Pathophysiology of Vomiting
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...

